1. Ward JM, Barnes RMR: HLA antigens in persistent palmoplantar pustulosis and its relationship to psoriasis. Br J Dermatol 99:477, 1978
2. Asumalahti K et al: Genetic analysis of PSORS1 distinguishes guttate psoriasis and palmoplantar pustulosis. J Invest Dermatol 120:627, 2003
3. Campalani E et al: Apolipoprotein E gene polymorphisms are associated with psoriasis but do not determine disease response to
acitretin.
Br J Dermatol 154:345, 2006
4. Mössner R et al: Association of TNF-238 and -308 promotor polymorphisms with psoriasis vulgaris and psoriatic arthritis but not with pustulosis palmoplantaris. J Invest Dermatol 124:282, 2005
5. Hashigucci K et al: A clinical feature associated with polymorphisms of the TNF region in Japanese patients with palmoplantar pustulosis. Hum Immunol 64:530, 2003
6. Kingo K et al: Association analysis of IL19, IL20 and IL24 genes in palmoplantar pustulosis. Br J Dermatol 156:646-652, 2007
7. Kuijpers AL et al: Skin-derived antileukoprotease (SKALP) is decreased in pustular forms of psoriasis: A clue to the pathogenesis of pustule formation? Arch Dermatol Res 288:641, 1996
8. Nakamura K et al: Exacerbation of pustulosis palmaris et plantaris after topical application of metals accompanied by elevated levels of leukotriene B4 in pustules. J Am Acad Dermatol 42:1021, 2000
9. Akiyama T et al: Relationships of onset and exacerbation of pustulosis palmaris et plantaris to smoking and focal infections. J Dermatol 22:930, 1995
10. Asada H et al: Evaluation of provocation test monitoring palmoplantar temperature with the use of thermography for diagnosis of focal tonsillar infection in palmoplantar pustulosis. J Dermatol Sci 32:105, 2003
11. Hagforsen E et al: Palmoplantar pustulosis: An autoimmune disease precipitated by smoking? Acta Derm Venereol 82:341, 2002
12. Michaelsson G et al: The psoriasis variant palmoplantar pustulosis can be improved after cessation of smoking. J Am Acad Dermatol 54:737, 2006
13. Hagforsen E et al: Expression of nicotinic receptors in the skin of patients with palmoplantar pustulosis. Br J Dermatol 146:383, 2002
14. Hagforsen E: The cutaneous non-neuronal cholinergic system and smoking related dermatoses: Studies of the psoriasis variant palmoplantar pustulosis. Life Sci 80:2227-2234, 2007
15. Koshiba S et al: Tonsillar crypt epithelium of palmoplantar pustulosis secretes interleukin-6 to support B-cell development via p63/p73 transcription factors. J Pathol 214:75-84, 2008
16. Nakamura T et al: Serum levels of interleukin 6 in patients with pustulosis palmaris et plantaris. J Dermatol 20:763-766, 1993.
17. Sakiyama H et al: Possible involvement of T cell co-stimulation in pustulosis palmaris et plantaris via the induction of inducible co-stimulator in chronic focal infections. J Dermatol Sci 50:197-207, 2008
18. Nozawa H et al: Expression of cutaneous lymphocyte-associated antigen (CLA) in tonsillar T-cells and its induction by in vitro stimulation with alpha-streptococci in patients with pustulosis palmaris et plantaris (PPP). Clin Immunol 116:42-53, 2005
19. Hayashi M et al: Pathogenic role of tonsillar lymphocytes in associated with HSP60/65 in pustulosis palmaris et plantaris. Auris Nasus Larynx 36:578-585, 2009
20. Yoshizaki T et al: Up-regulation of CC chemokine receptor 6 on tonsillar T cells and its induction by in vitro stimulation with alpha-streptococci in patients with pustulosis palmaris et plantaris. Clin Exp Immunol 157:71-82, 2009
21. Rallis E et al: Onset of palmoplantar pustular psoriasis while on
adalimumab for psoriatic arthritis: A ‘class effect’ of TNF-alpha antagonists or simply an anti-psoriatic treatment adverse reaction?
J Dermatolog Treat 1:1-3, 2009
22. Seneschal J et al: Cytokine imbalance with increased production of interferon-alpha in psoriasiform eruptions associated with antitumour necrosis factor-alpha treatments. Br J Dermatol 161:1081-1088, 2009
23. Ma HL et al: Tumor necrosis factor alpha blockade exacerbates murine psoriasis-like disease by enhancing Th17 function and decreasing expansion of Treg cells. Arthritis Rheum 62:430-440, 2010
24. Sasaki T: A case with osteomyelitis of the bilateral clavicles associated with pustulosis palmaris et plantaris. Rinsho Sei Keigara 2:333, 1967
25. Bergdahl K et al: Pustulosis palmoplantaris and its relation to chronic recurrent multifocal osteomyelitis. Dermatologica 159:37, 1979
26. Hradil E et al: Skeletal involvement in pustulosis palmo-plantaris with special reference to the sternocostoclavicular joints. Acta Derm Venereol 68:65, 1988
27. Benhamou CL, Chamot AM, Kahn MF: Synovitis-acne-pustulosis-hyperostosis-osteomyelitis syndrome (SAPHO): A new syndrome among the spondyloarthropathies? Clin Exp Rheumatol 6:109, 1988
28. Kahn MF, Chamot AM: SAPHO syndrome. Rheum Dis Clin North Am 18:225, 1992
29. Michaelsson G, Gerden B: How common is gluten intolerance among patients with psoriasis? Acta Derm Venereol 71:90, 1991
30. Michaëlsson G et al: Palmoplantar pustulosis and gluten sensitivity: A study of serum antibodies against gliadin and tissue transglutaminase, the duodenal mucosa and effects of gluten-free diet. Br J Dermatol 156:659-666, 2007
31. Eriksson MO et al: Palmoplantar pustulosis: A clinical and immunohistochemical study. Br J Dermatol 138:390, 1998
32. Toritsugi M et al: A vesiculopustular variant of mycosis fungoides palmaris et plantaris masquerading as palmoplantar pustulosis with nail involvement. J Am Acad Dermatol 51:139, 2004
33. Yung A, Merchant W, Sheehan-Dare R: Streptococcus induced pustular vasculitis affecting the hands resembling pustular vasculitis of the hands—First reported case. Clin Exp Dermatol 30:366, 2005
34. Chalmers R et al: Interventions for chronic palmoplantar pustulosis. The Cochrane Library 4:1-49, 2009
35. Adison E et al: A retrospective analysis of treatment responses of palmoplantar psoriasis in 114 patients. J Eur Acad Dermatol Venereol 23:814-819, 2009
36. Ständer H et al: Efficacy of fumaric acid ester monotherapy in psoriasis pustulosa palmoplantaris. Br J Dermatol 149:220, 2003
37. V'lckova-Laskoska MT et al: Palmoplantar pustulosis treated with
itraconazole: A single, active-arm pilot study.
Dermatol Ther 22:85-89, 2009
38. Guenther LC: Alefacept is safe and efficacious in the treatment of palmar plantar pustulosis. J Cutan Med Surg 11:202-205, 2007
39. Carr D et al: Open label trial of alefacept in palmoplantar pustular psoriasis. J Dermatolog Treat 19:97-100, 2008
40. Michaëlsson G et al:
Infliximab can precipitate as well as worsen palmoplantar pustulosis: Possible linkage to the expression of tumor necrosis factor-alpha in normal palmar eccrine sweat duct?
Br J Dermatol 153:1243, 2005
41. Baeten D et al: Systematic safety follow-up in a cohort of 107 patients with spondyloarthropathy treated with
infliximab: A new perspective on the role of host defence in the pathogenesis of the disease?
Ann Rheum Dis 62:829, 2003
42. Massara A, Cavazzini PL, Trotta F: In SAPHO syndrome anti-TNF therapy may induce persistent amelioration of osteoarticular complaints, but may exacerbate cutaneous manifestations. Rheumatology 45:730, 2006
43. Bissonnette R et al:
Etanercept in the treatment of palmoplantar pustulosis.
J Drugs Dermatol 7:940-946, 2008
44. Crocker HR: Diseases of the Skin. London, HK Lewis, 1888
45. Hallopeau H: Sur une asphyxie locale des extrémités avec polydactylite suppurative chronique et pussées éphéméres des dermatite pustuleuse disséminées et symmétriques. Ann Dermatol Syphiligr (Paris) 1:420, 1890
46. Kuijpers AL, van Dooren-Greebe RJ, van de Kerkhof PC: Acrodermatitis continua of Hallopeau: Response to combined treatment with
acitretin and calcipotriol ointment.
Dermatology 192:357, 1996
47. Nikkels AF, Nikkels-Tassoudji N, Pierard GE: Breaking the relentless course of Hallopeau's acrodermatitis by
dapsone.
Eur J Dermatol 9:126, 1999
48. Wilsmann-Theis D et al: Successful treatment of acrodermatitis continua suppurativa with topical
tacrolimus 0.1% ointment.
Br J Dermatol 150:1194, 2004
49. Puig L et al: Treatment of acrodermatitis continua of Hallopeau with TNF-blocking agents: Case report and review. Dermatology 220:154, 2010